Ana María Barragán
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ana María Barragán has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Pérez
Biostatistics and Data Science, The University of Texas Health Science Center at Houston (UTHealth), School of Public Health in Austin, Austin, Texas, USA
4 shared publications - Maria Ximena Rojas-Reyes
Department of Clinical Epidemiology and Public Health; Institut d'Recerca Hospital de la Santa Creu i Sant Pau (IR Sat Pau); Barcelona Spain
4 shared publications - Rodolfo Jose Dennis
Fundación CardioInfantil, Bogotá, Colômbia
4 shared publications - Augusto Peñaranda
Fundación Santa Fe de Bogota, Bogota, Colombia
3 shared publications - Martín Rondón
Pontificia Universidad Javeriana
3 shared publications - Elizabeth García
Fundación Santa Fe de Bogota
2 shared publications
Latest Publications
- Open Access
- 13 September 2026
- Published by Asociacion Colombiana de Infectologia - ACIN in Infectio
- p. 254-261
Comparison between two blood collection techniques for the diagnosis of bacteremia in patients with sepsis: unique blood culture vs. the standard method of multiple blood cultures
Introduction: In clinical practice, bloodstream infections, which often occur alongside sepsis, remain among the most serious and life-threatening conditions, with mortality rates as high as 50%. This study aimed to compare the diagnostic performance of a single venipuncture blood culture strategy (30 mL) with the standard method of multiple blood cultures in patients with sepsis. Materials and methods: A prospective paired within-patient diagnostic comparison study was conducted at the Fundación Cardioinfantil (Bogotá, Colombia) between April 2019 and May 2020. Adult patients with sepsis (SOFA >2) for whom blood cultures were ordered by the treating physician were included in the study. Each patient underwent three venipunctures according to the institutional protocol (10 mL each), and an additional 30 mL sample was collected through a single venipuncture for blood culture. A total of 113 patients were included in the analysis. Results: The single blood culture technique showed a relative sensitivity of 97.6% (95% CI: 87.1–99.9) and relative specificity of 95.8% (95% CI: 88.3–99.1), with high agreement between both strategies (AUC 0.967; 95% CI: 0.934–1). Compared to the standard technique, the single blood culture demonstrated a comparable diagnostic yield while reducing collection time and patient discomfort. Discussion: The single blood culture technique (30 mL) may represent a feasible and les invasive alternative, showing comparable diagnostic yield and agreement with the standard method. These findings should be interpreted as a comparison between sampling strategies, given the absence of a truly independent gold standard. Multicenter studies with larger blood volumes are needed to confirm these findings, and their impact on clinical outcomes should be evaluated before supporting their incorporation into clinical practice guidelines.
- 13 September 2026
- Published by Asociacion Colombiana de Infectologia - ACIN in Infectio
- p. 254-261
Open AccessComparison between two blood collection techniques for the diagnosis of bacteremia in patients with sepsis: unique blood culture vs. the standard method of multiple blood cultures
Introduction: In clinical practice, bloodstream infections, which often occur alongside sepsis, remain among the most serious and life-threatening conditions, with mortality rates as high as 50%. This study aimed to compare the diagnostic performance of a single venipuncture blood culture strategy (30 mL) with the standard method of multiple blood cultures in patients with sepsis. Materials and methods: A prospective paired within-patient diagnostic comparison study was conducted at the Fundación Cardioinfantil (Bogotá, Colombia) between April 2019 and May 2020. Adult patients with sepsis (SOFA >2) for whom blood cultures were ordered by the treating physician were included in the study. Each patient underwent three venipunctures according to the institutional protocol (10 mL each), and an additional 30 mL sample was collected through a single venipuncture for blood culture. A total of 113 patients were included in the analysis. Results: The single blood culture technique showed a relative sensitivity of 97.6% (95% CI: 87.1–99.9) and relative specificity of 95.8% (95% CI: 88.3–99.1), with high agreement between both strategies (AUC 0.967; 95% CI: 0.934–1). Compared to the standard technique, the single blood culture demonstrated a comparable diagnostic yield while reducing collection time and patient discomfort. Discussion: The single blood culture technique (30 mL) may represent a feasible and les invasive alternative, showing comparable diagnostic yield and agreement with the standard method. These findings should be interpreted as a comparison between sampling strategies, given the absence of a truly independent gold standard. Multicenter studies with larger blood volumes are needed to confirm these findings, and their impact on clinical outcomes should be evaluated before supporting their incorporation into clinical practice guidelines.
- Open Access
- 14 August 2026
- Published by Wiley in Cochrane Evidence Synthesis and Methods
- Vol. 4 (5) , e70098
Artificial Intelligence Resources for the Screening of Titles and Abstracts in Systematic Reviews: A Scoping Review
Introduction: Artificial intelligence (AI) is a branch of technology enabling machines to emulate complex human skills; it can also entail problem‐solving using bioinspired methods. It is used for automating systematic literature reviews (SLR), that is, defining a clinical question, locating relevant literature, preliminary screening, study evaluation, data extraction and analysis. Title and abstract screening is one of the most time‐consuming and error‐prone phases involved in developing a systematic review. While AI promises to expedite this process, adopting it faces challenges due to concerns about compatibility and transparency. This review aims to identify current evidence concerning AI use during preliminary SLR reference screening; it describes characteristics such as the different metrics used for reporting performance and how the different algorithms, pipelines, workflows or web applications are validated. AI resource users' reflections regarding SLR screening automation have also been summarized. Methods: A scoping review was conducted following Joanna Briggs Institute's (JBI) methodology. Its objective was to identify existing evidence regarding the use of AI resources for title and abstract screening automation. Searches were limited to articles published between 2019 and 2026. The review included primary studies reporting the development, assessment, validation, or real‐world use of AI resources for screening automation, as well as systematic reviews and articles reporting experiences or recommendations for their use. Two types of data were extracted: (1) from primary studies—characteristics of AI resources and, where applicable, recommendations for their use; (2) from systematic reviews and experience‐based articles, recommendations for the use of AI resources. Results included frequency descriptions, tables, figures, and a decision flowchart reflecting the number of references and articles retrieved, excluded, or included in the final analysis. Results: A total of 174 unique studies published between 2019 and 2026 were included in this scoping review. These were grouped into web applications (43%), model comparisons (32%), generative models (6%), pre‐trained models (3%) or pipelines/workflows (15%) used for title and abstract screening in systematic literature review (SLR). Most studies came from North America. Evaluating these tools often relied on retrospective comparisons with human reviewers' work (63%), sensitivity ( n = 60), and specificity ( n = 62) being the most reported metric for criterion assessment and Work Saved over Sampling ( n = 28) being the most reported metric for assessing their utility. Considerations concerning AI resource use focused on the need for standardized evaluation metrics, stopping criteria, study design and the data sets used, resource characteristics facilitating usability, best practice and future research areas, with the persistence of the human component in the process ( n = 26) being the most pressing recommendation. Conclusion: The findings indicated substantial heterogeneity regarding the types of AI resources used, considerable variation concerning the metrics used for reporting performance, differences in how such metrics are defined and a clear need for standardizing reporting methods, study designs and related procedures. Although AI technologies will continue to evolve, maintaining a clear and consistent framework for interpreting research on AI resources for automating title and abstract screening can support understanding their level of maturity and facilitate informed decision‐making by users.
- 14 August 2026
- Published by Wiley in Cochrane Evidence Synthesis and Methods
- Vol. 4 (5) , e70098
Open AccessArtificial Intelligence Resources for the Screening of Titles and Abstracts in Systematic Reviews: A Scoping Review
Introduction: Artificial intelligence (AI) is a branch of technology enabling machines to emulate complex human skills; it can also entail problem‐solving using bioinspired methods. It is used for automating systematic literature reviews (SLR), that is, defining a clinical question, locating relevant literature, preliminary screening, study evaluation, data extraction and analysis. Title and abstract screening is one of the most time‐consuming and error‐prone phases involved in developing a systematic review. While AI promises to expedite this process, adopting it faces challenges due to concerns about compatibility and transparency. This review aims to identify current evidence concerning AI use during preliminary SLR reference screening; it describes characteristics such as the different metrics used for reporting performance and how the different algorithms, pipelines, workflows or web applications are validated. AI resource users' reflections regarding SLR screening automation have also been summarized. Methods: A scoping review was conducted following Joanna Briggs Institute's (JBI) methodology. Its objective was to identify existing evidence regarding the use of AI resources for title and abstract screening automation. Searches were limited to articles published between 2019 and 2026. The review included primary studies reporting the development, assessment, validation, or real‐world use of AI resources for screening automation, as well as systematic reviews and articles reporting experiences or recommendations for their use. Two types of data were extracted: (1) from primary studies—characteristics of AI resources and, where applicable, recommendations for their use; (2) from systematic reviews and experience‐based articles, recommendations for the use of AI resources. Results included frequency descriptions, tables, figures, and a decision flowchart reflecting the number of references and articles retrieved, excluded, or included in the final analysis. Results: A total of 174 unique studies published between 2019 and 2026 were included in this scoping review. These were grouped into web applications (43%), model comparisons (32%), generative models (6%), pre‐trained models (3%) or pipelines/workflows (15%) used for title and abstract screening in systematic literature review (SLR). Most studies came from North America. Evaluating these tools often relied on retrospective comparisons with human reviewers' work (63%), sensitivity ( n = 60), and specificity ( n = 62) being the most reported metric for criterion assessment and Work Saved over Sampling ( n = 28) being the most reported metric for assessing their utility. Considerations concerning AI resource use focused on the need for standardized evaluation metrics, stopping criteria, study design and the data sets used, resource characteristics facilitating usability, best practice and future research areas, with the persistence of the human component in the process ( n = 26) being the most pressing recommendation. Conclusion: The findings indicated substantial heterogeneity regarding the types of AI resources used, considerable variation concerning the metrics used for reporting performance, differences in how such metrics are defined and a clear need for standardizing reporting methods, study designs and related procedures. Although AI technologies will continue to evolve, maintaining a clear and consistent framework for interpreting research on AI resources for automating title and abstract screening can support understanding their level of maturity and facilitate informed decision‐making by users.
- Open Access
- 10 April 2026
- Published by Elsevier in Journal of Affective Disorders
- Vol. 407, 121741
Depression and anxiety in adults with epilepsy. Systematic literature review and meta-analysis
- 10 April 2026
- Published by Elsevier in Journal of Affective Disorders
- Vol. 407, 121741
Open AccessDepression and anxiety in adults with epilepsy. Systematic literature review and meta-analysis
- Open Access
- 19 December 2025
- Published by Wiley
Artificial intelligence resources for the screening of titles and abstracts in systematic reviews: a scoping review
Introduction: Artificial intelligence (AI) is a branch of technology enabling machines to emulate complex human skills; it can also entail problem-solving using bioinspired methods. It is used for automating systematic literature reviews (SLR), i.e., defining a clinical question, locating relevant literature, preliminary screening, study evaluation, data extraction and analysis. Preliminary reference screening is one of the most time-consuming and error-prone phases involved in developing a systematic review. While AI promises to expedite this process, adopting it faces challenges due to concerns about compatibility and transparency. This review has been aimed at identifying current evidence concerning AI use during preliminary SLR reference screening; it describes characteristics such as the different metrics used for reporting performance and how the different algorithms, pipelines, workflows or web applications are validated. AI resource users’ reflections regarding SLR screening automation have also been summarised. Methods: A scoping review was conducted following Joanna Briggs Institute’s (JBI) methodology; its objective was to identify existing evidence regarding the use of AI-based resources for preliminary reference screening, aimed at identifying AI resources’ characteristics, dataset subset areas, the metrics reported for assessing an AI tool’s performance, such tool’s usefulness and open-source code use. Such searches were limited to articles published between 2019 and 2025; the results included frequency description, tables and figures and a decision flowchart reflecting the amount of references and articles retrieved, excluded from, or included in the final analysis. Likewise, article authors’ experiences of AI-based preliminary reference screening were also compiled. Results: The scoping review identified 99 studies published from 2019 to 2025 which were then grouped as web applications, model comparisons, generative models, pre-trained models or pipelines/workflows used for preliminary systematic literature review (SLR) reference screening. Most studies came from North America and Europe. Evaluating these tools often relied on retrospective comparisons with human reviewers’ work, workload reduction being the most reported metric for assessing their utility. Considerations concerning AI resource use focused on the need for standardised evaluation metrics, stopping criteria, study design and the data sets used, resource characteristics facilitating usability, best practice and future research areas. Conclusion: The findings indicated substantial heterogeneity regarding the types of AI resources used, considerable variation concerning the metrics used for reporting performance, differences in how such metrics are defined and a clear need for standardising reporting methods, study designs and related procedures.
- 19 December 2025
- Published by Wiley
Open AccessArtificial intelligence resources for the screening of titles and abstracts in systematic reviews: a scoping review
Introduction: Artificial intelligence (AI) is a branch of technology enabling machines to emulate complex human skills; it can also entail problem-solving using bioinspired methods. It is used for automating systematic literature reviews (SLR), i.e., defining a clinical question, locating relevant literature, preliminary screening, study evaluation, data extraction and analysis. Preliminary reference screening is one of the most time-consuming and error-prone phases involved in developing a systematic review. While AI promises to expedite this process, adopting it faces challenges due to concerns about compatibility and transparency. This review has been aimed at identifying current evidence concerning AI use during preliminary SLR reference screening; it describes characteristics such as the different metrics used for reporting performance and how the different algorithms, pipelines, workflows or web applications are validated. AI resource users’ reflections regarding SLR screening automation have also been summarised. Methods: A scoping review was conducted following Joanna Briggs Institute’s (JBI) methodology; its objective was to identify existing evidence regarding the use of AI-based resources for preliminary reference screening, aimed at identifying AI resources’ characteristics, dataset subset areas, the metrics reported for assessing an AI tool’s performance, such tool’s usefulness and open-source code use. Such searches were limited to articles published between 2019 and 2025; the results included frequency description, tables and figures and a decision flowchart reflecting the amount of references and articles retrieved, excluded from, or included in the final analysis. Likewise, article authors’ experiences of AI-based preliminary reference screening were also compiled. Results: The scoping review identified 99 studies published from 2019 to 2025 which were then grouped as web applications, model comparisons, generative models, pre-trained models or pipelines/workflows used for preliminary systematic literature review (SLR) reference screening. Most studies came from North America and Europe. Evaluating these tools often relied on retrospective comparisons with human reviewers’ work, workload reduction being the most reported metric for assessing their utility. Considerations concerning AI resource use focused on the need for standardised evaluation metrics, stopping criteria, study design and the data sets used, resource characteristics facilitating usability, best practice and future research areas. Conclusion: The findings indicated substantial heterogeneity regarding the types of AI resources used, considerable variation concerning the metrics used for reporting performance, differences in how such metrics are defined and a clear need for standardising reporting methods, study designs and related procedures.
- Open Access
- 25 January 2025
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 41 (1) , 2456578
Evaluation of the evidence-based practices for the management of PCOS in the Latin America context: the consensus of the Latin American Association of Gynecological Endocrinology (ALEG)
Polycystic Ovary Syndrome (PCOS) is a complex condition affecting approximately 1 in 10 women of reproductive age. However, limited data are available regarding the specific characteristics and needs of women with PCOS in Latin America. This consensus sought to evaluate the evidence-based practices for the management of PCOS for Latin American populations, consolidate regional insights, identify eventual gaps in implementation and identify key research opportunities. Using the Delphi strategy, experts from various Latin American countries selected and reviewed a subset of recommendations from the 2023 International Evidence-Based Guideline (EBG) for the Assessment and Management of PCOS. Virtual and in-person meetings facilitated discussions on the selected recommendations, followed by voting rounds to achieve consensus. A total of 33 recommendations for PCOS diagnosis and treatment were evaluated. In the initial voting round, 25 recommendations achieved strong agreement (80%-100% support), while eight received less than 80% agreement. After further discussions on their relevance and potential to influence behavior change among health professionals and public health policies, the remaining recommendations achieved near-unanimous support in the second round. This consensus underscored evidence-based practices for PCOS diagnosis and treatment deemed appropriate for the Latin American context. It also highlighted implementation barriers such as cost and accessibility, while identifying opportunities for research to improve PCOS management and address regional challenges. These findings aim to enhance clinical care and inform public health strategies tailored to the needs of Latin American women living with PCOS.
- 25 January 2025
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 41 (1) , 2456578
Open AccessEvaluation of the evidence-based practices for the management of PCOS in the Latin America context: the consensus of the Latin American Association of Gynecological Endocrinology (ALEG)
Polycystic Ovary Syndrome (PCOS) is a complex condition affecting approximately 1 in 10 women of reproductive age. However, limited data are available regarding the specific characteristics and needs of women with PCOS in Latin America. This consensus sought to evaluate the evidence-based practices for the management of PCOS for Latin American populations, consolidate regional insights, identify eventual gaps in implementation and identify key research opportunities. Using the Delphi strategy, experts from various Latin American countries selected and reviewed a subset of recommendations from the 2023 International Evidence-Based Guideline (EBG) for the Assessment and Management of PCOS. Virtual and in-person meetings facilitated discussions on the selected recommendations, followed by voting rounds to achieve consensus. A total of 33 recommendations for PCOS diagnosis and treatment were evaluated. In the initial voting round, 25 recommendations achieved strong agreement (80%-100% support), while eight received less than 80% agreement. After further discussions on their relevance and potential to influence behavior change among health professionals and public health policies, the remaining recommendations achieved near-unanimous support in the second round. This consensus underscored evidence-based practices for PCOS diagnosis and treatment deemed appropriate for the Latin American context. It also highlighted implementation barriers such as cost and accessibility, while identifying opportunities for research to improve PCOS management and address regional challenges. These findings aim to enhance clinical care and inform public health strategies tailored to the needs of Latin American women living with PCOS.
- 29 July 2024
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 32 (10) , 2388-2404
Clinical Characteristics of Ocular Mucous Membrane Pemphigoid: A Systematic Review and Meta-Analysis
Mucous membrane pemphigoid (MMP) is a systemic, immune-mediated, chronic disease characterized by the development of subepithelial blisters due to the presence of autoantibodies directed against st...
- 29 July 2024
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 32 (10) , 2388-2404
Clinical Characteristics of Ocular Mucous Membrane Pemphigoid: A Systematic Review and Meta-Analysis
Mucous membrane pemphigoid (MMP) is a systemic, immune-mediated, chronic disease characterized by the development of subepithelial blisters due to the presence of autoantibodies directed against st...
- Open Access
- 1 January 2024
- Published by Wiley in Journal of Diabetes Research
- Vol. 2024 (1) , 5902036
Diagnostic Accuracy of Screening Tests for Diabetic Peripheral Neuropathy: An Umbrella Review
Peripheral neuropathy is a common cause of morbidity in diabetes. Despite recent advancements in early diagnosis methods, there is a need for practical, highly sensitive, and cost‐effective screening methods in clinical practice. This study summarizes evidence from systematic reviews and meta‐analyses on the diagnostic accuracy of validated screening methods for diabetic peripheral neuropathy. Two independent reviewers assessed methodological quality and bias using AMSTAR and ROBIS tools. Seven reviews with 19,531 participants were included. The monofilament test showed inconsistent sensitivity (S: 0.53–0.93) and specificity (Sp: 0.64–1.00), along with high variability in its application. Neuropad exhibited high S (86%, 95% CI 79–91). However, variations in the interpretation of results across the included studies may have impacted its Sp (65%, 95% CI 51–76). The Ipswich touch test exhibited adequate diagnostic accuracy (S: 0.77, Sp: 0.96, DOR: 75.24) but lacked comparison with gold standard tests. In vibration perception studies, the biothesiometer outperformed the tuning fork (S: 0.61–0.80 vs. 0.10–0.46). In general, heterogeneity was observed due to varied reference tests, thresholds, and patient differences. The development of automated analysis methods, as well as determination of predictive value of the combination of screening tools, is needed for further studies. Based on the study results, we suggest that clinicians should select screening tools tailored to their patient population, clinical setting, and available resources, as no single test can be universally recommended for all clinical scenarios.
- 1 January 2024
- Published by Wiley in Journal of Diabetes Research
- Vol. 2024 (1) , 5902036
Open AccessDiagnostic Accuracy of Screening Tests for Diabetic Peripheral Neuropathy: An Umbrella Review
Peripheral neuropathy is a common cause of morbidity in diabetes. Despite recent advancements in early diagnosis methods, there is a need for practical, highly sensitive, and cost‐effective screening methods in clinical practice. This study summarizes evidence from systematic reviews and meta‐analyses on the diagnostic accuracy of validated screening methods for diabetic peripheral neuropathy. Two independent reviewers assessed methodological quality and bias using AMSTAR and ROBIS tools. Seven reviews with 19,531 participants were included. The monofilament test showed inconsistent sensitivity (S: 0.53–0.93) and specificity (Sp: 0.64–1.00), along with high variability in its application. Neuropad exhibited high S (86%, 95% CI 79–91). However, variations in the interpretation of results across the included studies may have impacted its Sp (65%, 95% CI 51–76). The Ipswich touch test exhibited adequate diagnostic accuracy (S: 0.77, Sp: 0.96, DOR: 75.24) but lacked comparison with gold standard tests. In vibration perception studies, the biothesiometer outperformed the tuning fork (S: 0.61–0.80 vs. 0.10–0.46). In general, heterogeneity was observed due to varied reference tests, thresholds, and patient differences. The development of automated analysis methods, as well as determination of predictive value of the combination of screening tools, is needed for further studies. Based on the study results, we suggest that clinicians should select screening tools tailored to their patient population, clinical setting, and available resources, as no single test can be universally recommended for all clinical scenarios.
- 15 December 2022
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 105, 43-51
Dysautonomia in people with epilepsy: A scoping review
- 15 December 2022
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 105, 43-51
Dysautonomia in people with epilepsy: A scoping review
- 22 March 2018
- Published by Instituto Nacional de Salud (Colombia) in Biomédica
- Vol. 38 (4) , 577-585
Calidad de vida y apoyo social percibido en personas con VIH en Bogotá, Colombia
Introducción. Las personas que viven con VIH/SIDA refieren menor calidad de vida y menor apoyo social en evidencia proveniente de países desarrollados.Objetivo. Explorar la asociación entre apoyo social percibido; afectivo o de confianza y cada dimensión de calidad de vida relacionada con salud.Materiales y métodos. Estudio de corte transversal en personas que viven con VIH/SIDA seleccionadas por conveniencia de un programa de atención en una red hospitalaria de Bogotá. Se utilizaron los cuestionarios de calidad de vida relacionada con la salud SF36 y el cuestionario genérico de apoyo social funcional Duke-UNC-11. Se realizaron modelos de regresión lineal.Resultados. Existe relación directa entre la dimensión de bienestar emocional de calidad de vida y apoyo social afectivo (β: 7.36 IC95%: 1.04; 13.68) y de confianza (β 11.63 IC95% 5.30; 17.96). También entre las dimensiones de función física, desempeño emocional y dolor corporal y apoyo social percibido de tipo afectivo y entre la percepción de apoyo social de confianza y las dimensiones de vitalidad y función social. En contraposición, se encontró relación inversa entre los promedios de los puntajes de las dimensiones de desempeño emocional, desempeño físico y salud general con apoyo social percibido de tipo afectivo para la primera dimensión y de confianza para las dos últimas.Conclusiones. Los sujetos con mejores niveles de apoyo social percibido tienen un mejor nivel reportado de calidad de vida relacionada con la salud, situación que brinda insumos para la planeación, diseño e implementación de planes de atención médica que incorporen variables clínicas, paraclínicas y del entorno del paciente.
- 22 March 2018
- Published by Instituto Nacional de Salud (Colombia) in Biomédica
- Vol. 38 (4) , 577-585
Calidad de vida y apoyo social percibido en personas con VIH en Bogotá, Colombia
Introducción. Las personas que viven con VIH/SIDA refieren menor calidad de vida y menor apoyo social en evidencia proveniente de países desarrollados.Objetivo. Explorar la asociación entre apoyo social percibido; afectivo o de confianza y cada dimensión de calidad de vida relacionada con salud.Materiales y métodos. Estudio de corte transversal en personas que viven con VIH/SIDA seleccionadas por conveniencia de un programa de atención en una red hospitalaria de Bogotá. Se utilizaron los cuestionarios de calidad de vida relacionada con la salud SF36 y el cuestionario genérico de apoyo social funcional Duke-UNC-11. Se realizaron modelos de regresión lineal.Resultados. Existe relación directa entre la dimensión de bienestar emocional de calidad de vida y apoyo social afectivo (β: 7.36 IC95%: 1.04; 13.68) y de confianza (β 11.63 IC95% 5.30; 17.96). También entre las dimensiones de función física, desempeño emocional y dolor corporal y apoyo social percibido de tipo afectivo y entre la percepción de apoyo social de confianza y las dimensiones de vitalidad y función social. En contraposición, se encontró relación inversa entre los promedios de los puntajes de las dimensiones de desempeño emocional, desempeño físico y salud general con apoyo social percibido de tipo afectivo para la primera dimensión y de confianza para las dos últimas.Conclusiones. Los sujetos con mejores niveles de apoyo social percibido tienen un mejor nivel reportado de calidad de vida relacionada con la salud, situación que brinda insumos para la planeación, diseño e implementación de planes de atención médica que incorporen variables clínicas, paraclínicas y del entorno del paciente.